Yael Vin, MD, MPH, FACS

Result-driven Chief Medical officer with over 20 years of experience in healthcare. Demonstrates clinical leadership by combining clinical expertise with strategic vision to drive organizational success. Strong background in clinical trial design and leading clinical strategies, while ensuring regulatory compliance. Skillful at developing and executing strategic initiatives. Committed to driving continuous innovation and excellence.

• Vin Y, Matyal R, Delude RL, Lee C, Creasey AA, Fink MP. Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock. Intensive Care Med. 2001 Aug;27(8):1274-80. (R. Matyal and Y. Vin contributed equally to this manuscript)
• Newman LA, Mason J, Cote D, Vin Y, Carolin K, Bouwman D, Colditz GA. African-American ethnicity, socioeconomic status, and breast cancer survival: A meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer. 2002 Jun 1;94(11):2844-54.
• Vin Y, Sima CS, Getrajdman GI, Brown KT, Covey A, Brennan MF, Allen PJ. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg. 2008 Oct;207(4):490-8.
• DeSilva RN, Patibandla BK, Vin Y, Narra A, Chawla V, Brown RS, Goldfarb-Rumyantzev AS. Fistula first is not always the best strategy for the elderly. J Am Soc Nephrol. 2013 Jul;24(8):1297-304.
• Patibandla BK, Narra A, Desilva R, Chawla V, Vin Y, Brown RS, Goldfarb-Rumyantzev AS. Disparities in arteriovenous fistula placement in older hemodialysis patients. Hemodial Int. 2014 Jan;18(1):118-26.
• Hod T, Desilva RN, Patibandla BK, Vin Y, Brown RS, Goldfarb-Rumyantzev AS. Factors predicting failure of AV "fistula first" policy in the elderly. Hemodial Int. 2014 Apr;18(2):507-15.
• Goldfarb-Rumyantzev AS, Syed W, Patibandla BK, Narra A, Desilva R, Chawla V, Hod T, Vin Y. Geographic disparities in arteriovenous fistula placement in patients approaching hemodialysis in the United States. Hemodial Int. 2014 Jul;18(3):686-94.
• Hod T, Patibandla BK, Vin Y, Brown RS, Goldfarb-Rumyantzev AS. Arteriovenous fistula placement in the elderly: When is the optimal time? J Am Soc Nephrol. 2015 Feb;26(2):448-56.
• Bhavnish Bucktowarsing, Yael Vin, Edgar V Lerma. The Clinical Relevance and Management of High-Flow Arteriovenous Access. Adv Chronic Kidney Dis 2020 May;27(3):214-218.
• Kim MP, Vin Y, Parangi S. Image of the month. Enterolithotomy. Arch Surg. 2006 Jun;141(6):609-10.
• Vin Y, Matthews J B. Small bowel tumors. In: McNally PR, ed. GI/Liver Secrets, 2nd edition. Philadelphia: Hanley and Belfus, Inc., 2001: 312-318.
• Vin Y, Khwaja K. Dialysis Access. In: Atlas of Organ Transplantation, 2nd edition.

• Resident in General and Cardiothoracic Surgery, Hadassah Medical Center, Jerusalem, Israel, 12/1994, 10/1996
• Research Fellow, Beth Israel Deaconess Medical Center, 3/1997, 6/1998, Mitchell F. Fink
• Resident in General Surgery, Beth Israel Deaconess Medical Center, 6/1998, 6/2000, 6/2002 - 6/2005
• Research Fellow in General Surgery, Beth Israel Deaconess Medical Center, 6/2000, 6/2002, NIH training grant, Jeffery B. Matthews
• Fellow in Interventional Radiology and Image Guided Therapy, Memorial Sloan-Kettering Cancer Center, 7/2005, 6/2006

Recipient of the Kidney X Prize (2019) 

‘Drug Eluting Electrospun Hemodialysis Graft’ 

NIH SBIR Grant (2019) 

‘Slippery Omniphobic Coating for Hemodialysis Catheter to Improve Patency and Patient Outcomes’ (PI: Saibal Bandyopadhyay)